261 related articles for article (PubMed ID: 12697241)
21. JEM spotlight: Monitoring the treatment efficiency of a full scale ozonation on a sewage treatment plant with a mode-of-action based test battery.
Escher BI; Bramaz N; Ort C
J Environ Monit; 2009 Oct; 11(10):1836-46. PubMed ID: 19809706
[TBL] [Abstract][Full Text] [Related]
22. Removal of endocrine disruptors by tertiary treatments and constructed wetlands in subtropical Australia.
Chapman H
Water Sci Technol; 2003; 47(9):151-6. PubMed ID: 12830954
[TBL] [Abstract][Full Text] [Related]
23. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.
Clara M; Strenn B; Gans O; Martinez E; Kreuzinger N; Kroiss H
Water Res; 2005 Nov; 39(19):4797-807. PubMed ID: 16242170
[TBL] [Abstract][Full Text] [Related]
24. Combined chemical and biological oxidation of penicillin formulation effluent.
Alaton IA; Dogruel S; Baykal E; Gerone G
J Environ Manage; 2004 Nov; 73(2):155-63. PubMed ID: 15380320
[TBL] [Abstract][Full Text] [Related]
25. Liquid chromatography-(tandem) mass spectrometry for the follow-up of the elimination of persistent pharmaceuticals during wastewater treatment applying biological wastewater treatment and advanced oxidation.
Gebhardt W; Schröder HF
J Chromatogr A; 2007 Aug; 1160(1-2):34-43. PubMed ID: 17582426
[TBL] [Abstract][Full Text] [Related]
26. Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant.
Nakada N; Shinohara H; Murata A; Kiri K; Managaki S; Sato N; Takada H
Water Res; 2007 Nov; 41(19):4373-82. PubMed ID: 17632207
[TBL] [Abstract][Full Text] [Related]
27. Discussion on the application of UV/H(2)O(2), O(3) and O(3)/UV processes as technologies for sewage reuse considering the removal of pharmaceuticals and personal care products.
Kim IH; Yamashita N; Kato Y; Tanaka H
Water Sci Technol; 2009; 59(5):945-55. PubMed ID: 19273893
[TBL] [Abstract][Full Text] [Related]
28. Influence of mass transfer on the ozonation of wastewater from the glass fiber industry.
Byun S; Cho SH; Yoon J; Geissen SU; Vogelpohl A; Kim SM
Water Sci Technol; 2004; 49(4):31-6. PubMed ID: 15077944
[TBL] [Abstract][Full Text] [Related]
29. O(3) and O(3)/H(2)O(2) treatment of sulfonamide and macrolide antibiotics in wastewater.
Lin AY; Lin CF; Chiou JM; Hong PK
J Hazard Mater; 2009 Nov; 171(1-3):452-8. PubMed ID: 19589642
[TBL] [Abstract][Full Text] [Related]
30. Purification of cork processing wastewaters by ozone, by activated sludge, and by their two sequential applications.
Benitez FJ; Acero JL; Garcia J; Leal AI
Water Res; 2003 Oct; 37(17):4081-90. PubMed ID: 12946889
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of UV/H(2)O(2) treatment for the oxidation of pharmaceuticals in wastewater.
Rosario-Ortiz FL; Wert EC; Snyder SA
Water Res; 2010 Mar; 44(5):1440-8. PubMed ID: 19931113
[TBL] [Abstract][Full Text] [Related]
32. Catalyzed ozonation process with GAC and metal doped-GAC for removing organic pollutants.
Oh BS; Song SJ; Lee ET; Oh HJ; Kang JW
Water Sci Technol; 2004; 49(4):45-9. PubMed ID: 15077946
[TBL] [Abstract][Full Text] [Related]
33. Advanced oxidation of the pharmaceutical drug diclofenac with UV/H2O2 and ozone.
Vogna D; Marotta R; Napolitano A; Andreozzi R; d'Ischia M
Water Res; 2004 Jan; 38(2):414-22. PubMed ID: 14675653
[TBL] [Abstract][Full Text] [Related]
34. Fate of synthetic musks in a domestic wastewater treatment plant and in an agricultural field amended with biosolids.
Yang JJ; Metcalfe CD
Sci Total Environ; 2006 Jun; 363(1-3):149-65. PubMed ID: 16081141
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation.
Rosal R; Rodríguez A; Perdigón-Melón JA; Petre A; García-Calvo E; Gómez MJ; Agüera A; Fernández-Alba AR
Water Res; 2010 Jan; 44(2):578-88. PubMed ID: 19628245
[TBL] [Abstract][Full Text] [Related]
36. Measurement of the initial phase of ozone decomposition in water and wastewater by means of a continuous quench-flow system: application to disinfection and pharmaceutical oxidation.
Buffle MO; Schumacher J; Salhi E; Jekel M; von Gunten U
Water Res; 2006 May; 40(9):1884-94. PubMed ID: 16624368
[TBL] [Abstract][Full Text] [Related]
37. Biological treatability of raw and ozonated penicillin formulation effluent.
Cokgor EU; Alaton IA; Karahan O; Dogruel S; Orhon D
J Hazard Mater; 2004 Dec; 116(1-2):159-66. PubMed ID: 15561374
[TBL] [Abstract][Full Text] [Related]
38. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study.
Huber MM; Göbel A; Joss A; Hermann N; Löffler D; McArdell CS; Ried A; Siegrist H; Ternes TA; von Gunten U
Environ Sci Technol; 2005 Jun; 39(11):4290-9. PubMed ID: 15984812
[TBL] [Abstract][Full Text] [Related]
39. Removal of hormones and pharmaceuticals in the Advanced Water Recycling Demonstration Plant in Queensland, Australia.
Khan SJ; Wintgens T; Sherman P; Zaricky J; Schäfer AI
Water Sci Technol; 2004; 50(5):15-22. PubMed ID: 15497824
[TBL] [Abstract][Full Text] [Related]
40. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]